SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations

0 avis

SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations

Archive ouverte

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. Hyperactive SHP2 promotes inflammation-driven insulin resistance by skewing macrophage balance in metabolic tissues and may be a target in T2D.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor

Archive ouverte | Personnaz, Jean | CCSD

International audience. Dysregulations of lipid metabolism in the liver may trigger steatosis progression, leading to potentially severe clinical consequences such as nonalcoholic fatty liver diseases (NAFLDs). Mole...

The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?

Archive ouverte | Saint-Laurent, Céline | CCSD

International audience. The SH2 containing protein tyrosine phosphatase 2(SHP2) plays essential roles in fundamental signaling pathways, conferring on it versatile physiological functions during development and in h...

LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity

Archive ouverte | Tajan, Mylène | CCSD

International audience

Chargement des enrichissements...